Antiviral Drug Development

A Multidisciplinary Approach

Erik De Clercq, Richard T. Walker (Herausgeber)

Buch | Softcover

314 Seiten

2012 | Softcover reprint of the original 1st ed. 1988
Springer-Verlag New York Inc.
978-1-4684-7277-6 (ISBN)

Artikel merken

Antiviral Chemotherapy: An Introduction and Reasons for the Slow Progress, Particularly towards Rational Design.- Design of Nucleoside Analogs as Potential Antiviral Agents.- Design of Anti-Viral Agents other than Nucleoside Analogues.- Antivirals for High Hazards Viruses.- Human Retroviruses and Anti-Viral Therapies.- Epstein-Barr Virus.- Molecular Targets for Selective Antiviral Chemotherapy.- Inhibition of S-Adenosylmethionine-Dependent Transmethylation as an Approach to the Development of Antiviral Agents.- Assay Systems: Testing of Antiviral Drugs in Cell Culture (in vitro).- Animal Models as Assay Systems for the Development of Antivirals.- Experimental Aspects of Antiviral Pharmacology.- Virus Drug Resistance.- Interferon as an Antiviral Agent.- Risk-Benefit Analysis in Drug Research.- Safety Assessment of Antiviral Drugs.- Antiviral Agents: A New Beginning.- Participants.

Erscheint lt. Verlag	26.11.2012
Reihe/Serie	Nato Science Series: A ; 143
Zusatzinfo	13 Illustrations, black and white; VIII, 314 p. 13 illus.
Verlagsort	New York, NY
Sprache	englisch
Maße	170 x 244 mm
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Mikrobiologie / Infektologie / Reisemedizin
	Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie
	Medizin / Pharmazie ► Pharmazie
	Studium ► Querschnittsbereiche ► Infektiologie / Immunologie
	Naturwissenschaften ► Biologie ► Mikrobiologie / Immunologie
ISBN-10	1-4684-7277-1 / 1468472771
ISBN-13	978-1-4684-7277-6 / 9781468472776
Zustand	Neuware